A detailed history of Brewin Dolphin LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Brewin Dolphin LTD holds 1,100 shares of AZN stock, worth $72,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,100
Previous 1,100 -0.0%
Holding current value
$72,930
Previous $73,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$54.02 - $63.83 $59,422 - $70,213
1,100 New
1,100 $64,000
Q1 2021

Nov 09, 2023

SELL
$47.16 - $54.44 $33,012 - $38,108
-700 Reduced 43.75%
900 $44.7 Million
Q3 2020

Nov 09, 2023

BUY
$53.07 - $61.1 $84,912 - $97,760
1,600 New
1,600 $87.7 Million
Q1 2018

Nov 09, 2023

SELL
$32.97 - $36.63 $19,782 - $21,978
-600 Closed
0 $0
Q3 2017

Nov 09, 2023

SELL
$28.96 - $34.0 $14,480 - $17,000
-500
600 $20.3 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.